Latest News

Immune-modulating drug unexpectedly benefits mice with fatal mitochondrial defect

In a lab devoted to increasing healthy lifespans, the transplant anti-rejection drug rapamycin showed unexpected health benefits and increased survival in a mouse model of a fatal mitochondrial defect. Children with the untreatable condition suffer from brain damage and muscle weakness, and rarely live beyond 6 or 7 years. The drug enables the body to bypass the mitochondrial defect by switching its metabolism to burn fats and amino acids instead of glucose, and thereby reduces toxic byproducts.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Autism after high school: Making the transition

  • New technology shows promise for delivery of therapeutics to the brain

  • Higher suicide risk after served prison sentence

  • Major factor in development of Huntington's disease uncovered

  • Neglect of culture in medicine is 'single biggest barrier' to achieving better health

  • Different brain tumors have the same origin, new findings show

  • Politics can interact with evolution to shape human destiny

  • Heavy drinking in adolescence associated with lasting brain changes, animal study suggests

  • From age 8 to 80, expert reveals the price we pay for not sleeping

  • Evolution of competitiveness: Scientists explain diversity in competitiveness

  •